© 2013 Dr. Paul A. Foster. Proudly made by Wix.com

  • facebook-square
  • Twitter Square
  • LinkedIn Square

Anti-oestrogens inhibit colorectal tumourigenesis

January 28, 2014

New research (see it here) has shown that the anti-oestrogens raloxifene and gonadorelin block the formation of colorectal tumours in female mice genetically pre-disposed (so called ApcMin/+ mice) to develop colorectal cancer. Anti-oestrogens inhibited tumour formation by a massive 80% (raloxifene) and 75% (gonadorelin), and also inhibited colorectal cancer growth. Furthermore, results demonstrated that anti-oestrogen treatment also reduced the number of colon polyps (known to be precursors of colorectal cancer development). Intriguingly, anti-oestrogens also reduced local inflammation, a known pathway to colorectal cancer maturation.

 

These data support the growing evidence that oestrogens can exacerbate the formation of colorectal cancer, and that targeting oestrogen activation or signalling may provide a new therpy for patients with colorectal malignancies.

Please reload

Featured Posts

Anti-oestrogens inhibit colorectal tumourigenesis

January 28, 2014

1/1
Please reload

Recent Posts
Please reload

Search By Tags
Please reload

Follow Us
  • Facebook Classic
  • Twitter Classic
  • Google Classic